Product Catalog


SerpinG1 / C1IN Antibody
| Catalog | Size (Price) | Quantity | In Stock | Operation | Other Information |
| 10995-R018 |
|
YES |
|
![]() |
|
Plasma Protease C1 Inhibitor / C1-inhibiting Factor Antibody
| Order or Inquire for SerpinG1 Antibody product | ![]() |
||
| Detection limit is 0.5 ng/lane in WB | |||
| Detection limit is 0.00245 ng/well in ELISA |
SerpinG1 / C1IN Antibody Product Information
| Immunogen : |
Recombinant human SerpinG1 protein ( Catalog#10995-H08H ) |
| Antibody Type : | Rabbit Monoclonal Antibody ( Rabbit mAb Service Platform ) |
|
Clone ID : |
18 |
| Ig Type : |
Rabbit IgG |
| Formulation : | 0.2 μm filtered solution in PBS with 5% trehalose |
| Preparation : |
This antibody was obtained from a rabbit immunized with purified, human cell-derived, recombinant human SerpinG1 ( rh SerpinG1 ; Catalog#10995-H08H ; NP_000053.2 ; Met 1 - Ala 500 ). |
SerpinG1 / C1IN Antibody Usage Guide
|
Specificity : |
Human SerpinG1 / C1IN |
|
No cross-reactivity in ELISA with Human SerpinA1 / A1AT Human SerpinA3 / SERPINA3 / AACT Human SerpinA5 / PROCI Human SerpinC1 / SERPINC1 / Antithrombin-III Human SerpinD1 / SERPIND1 / HC2 Human SerpinF1 / SERPINF1 / PEDF Human SerpinF2 / SERPINF2 Human SerpinI1 / SERPINI1 / Protease inhibitor 12 |
|
| Western blot : | This antibody can be used at 1 - 2 μg/mL with the appropriate secondary reagents to detect human SERPING1 in WB. Using a DAB detection system, the detection limit for human SERPING1 is approximately 0.5 ng/lane under non-reducing conditions and reducing conditions |
| Direct ELISA : | This antibody can be used at 0.1 - 0.2 μg/mL with the appropriate secondary reagents to detect human SERPING1. The detection limit for human SERPING1 is approximately 0.00245 ng/well |
| Storage : | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free. Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles. |
SerpinG1 / C1IN Antibody Related Products & Topics
Related Areas:
Enzyme>>Protease & Regulator>>Serine Protease & Regulator>>Serpin Superfamily>>C1 inhibitor/SerpinG1
Immunology>>Innate Immunity>>Complement System>>C1 inhibitor/SerpinG1
Proteins:
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| C1 inhibitor/SerpinG1 | Human | C1 inhibitor/SerpinG1 Protein, Recombinant | 10995-H08H |
Antibodies:
| Molecule | Application | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Human C1 inhibitor/SerpinG1 |
WB, ELISA | Mouse Monoclonal Antibody | 10995-MM03 |
| Human C1 inhibitor/SerpinG1 |
WB, ELISA | C1 inhibitor/SerpinG1 Antibody, Rabbit MAb | 10995-R018 |
| Human C1 inhibitor/SerpinG1 |
WB, ELISA | Rabbit Polyclonal Antibody | 10995-RP01 |
| Human C1 inhibitor/SerpinG1 |
WB, ELISA | Rabbit Polyclonal Antibody (Antigen Affinity Purified) | 10995-RP02 |
SerpinG1 / C1IN Antibody Background
Plasma protease C1 inhibitor, also known as C1-inhibiting factor, C1-INH, C1 esterase inhibitor, SERPING1 and C1IN, is a serine protease inhibitor protein. C1-INH is the largest member among the serpin class of proteins. Remarkably, C1-INH has a 2-domain structure, unlike most family members. The C-terminal serpin domain is similar to other serpins, and this part of C1-INH provides the inhibitory activity. The N-terminal domain is not essential for C1-INH to inhibit proteinases and has no similarity to other proteins. The main function of C1-INH is the inhibition of the complement system to prevent spontaneous activation. C1-INH is an acute phase protein and circulates in blood at levels of around 0.25 g/L, whose levels rise 2-fold during inflammation. C1-INH irreversibly binds to and inactivates C1r and C1s proteinases in the C1 complex of classical pathway of complement. C1-INH prevents the proteolytic cleavage of later complement components C4 and C2 by C1 and MBL. Although named after its complement inhibitory activity, C1-INH also inhibits proteinases of the fibrinolytic, clotting, and kinin pathways. Most notably, C1-INH is the most important physiological inhibitor of plasma kallikrein, fXIa and fXIIa.
References
- Theriault, A. et al., 1990, Hum. Genet. 84 (5): 477-9.
- Davis, AE. et al., 2004, Drug News Perspect. 17 (7): 439-46.
- Koles, K. et al., 2004, Glycobiology. 14 (1): 51-64.
- Cicardi, M. et al., 2005, Springer Semin. Immunopathol. 27(3): 286-98.
- Bernstein, JA. et al., 2008, Ann. Allergy Asthma Immunol.100: S41-6.
+86-400-890-9989






